Biopol Chemicals IPO Review 2026: GMP Steady, Key Investor Insights

Biopol Chemicals IPO is open for bidding from 6th February 2026 to 10th February 2026. It is a bookbuilding IPO of ₹31.26 crore, comprising an entirely fresh issue of 0.29 crore shares. The issue will be listed on NSE and SME on its tentative listing date, 13th February 2026. 

Biopol Chemicals IPO Details 

The Biopol Chemicals IPO date is fixed between 6th February 2026 to 10th February 2026. The face value of Biopol Chemicals shares stands at ₹10 per share, and the IPO Issue price band is set at ₹102 to ₹108 per share

Bigshare Services Private Limited is the registrar of the Biopol Chemicals IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below. 

Biopol Chemicals IPO Share Reservation

Riddhi Display Equipment’s IPO is a bookbuilding issue of 0.29 crore shares worth ₹31.26 crore. Biopol Chemicals IPO Limited shares will be listed on the NSE and the SME Exchange. Furthermore, SEBI has specified the share reservation criteria for different investor categories. 

Biopol Chemicals IPO GMP Grey Market Premium

GMP is the gap between the issue price band and the price at which company shares are currently trading in the grey market. Do you want to get live updates on the Biopol Chemicals IPO? If yes, then you’ve reached the right spot. Check the table below to learn about the GMP trends.

As of 6th February 2026, Biopol Chemicals IPO GMP stands at ₹0.00 per share, which means the share will likely list at ₹108.00 on its tentative listing date, 13th February 2026.

GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Biopol Chemicals IPO GMP. Stay informed with Univest for real-time insights into IPOs and their GMP trends. 

Biopol Chemicals IPO GMP Review

Check out the detailed Biopol Chemicals GMP IPO review for a thorough understanding of its potential to report listing gains on 13th February 2026. The Biopol Chemicals IPO review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO. 

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the business’s economic growth and decline before applying for the Biopol Chemicals IPO.

Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Biopol Chemicals’ IPO has shown consistent revenue growth, indicating the company’s financial stability. Moreover, brokers, investors, and RAs have a positive outlook for the Biopol Chemicals IPO, with its tentative listing day set for 13th February 2026. 

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of the Biopol Chemicals IPO.

The P/E ratio of Biopol Chemicals Limited shares is 19.73, and its Earnings Per Share (EPS) stands at 5.47. Thus, the Biopol Chemicals IPO can deliver gains on its tentative listing date, 13th February 2026. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Biopol Chemicals Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

Biopol Chemicals IPO Subscription Status

The Biopol Chemicals IPO will open for bidding on 4th February 2026. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Biopol Chemicals IPO Subscription Status. 

About Biopol Chemicals Limited

Biopol Chemicals Limited was established in the year 2023. Biopol Chemicals Limited manufactures and distributes speciality chemicals, including silicones, emulsifiers, biochemicals, and polyelectrolytes. The company’s product offerings include 66 products, consisting of 40 silicone products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. These products are used across a variety of industries, including textiles, home care, agriculture, and industrial chemicals. The company operates on the business-to-business model, catering to institutional clients rather than retail end users. The company operates the 4 establishments located in West Bengal and Gujarat, which comprise their manufacturing unit, warehouse, and corporate office in West Bengal, and the registered office located in West Bengal.

Biopol Chemicals Limited Financials

The company’s financial analysis is essential before applying for the Biopol Chemicals IPO. See the table for Biopol Chemicals Limited’s financials. 

Explanation

Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Biopol Chemicals Limited IPO Promoter Holdings

Have a look at the table below to check the holdings of Ashish Kankaria, Shruti A. Kankaria, Ambica Capital Markets Limited, and Gold View Financial Services Limited.

Note: The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue.

Aim of the Biopol Chemicals IPO

The primary aim of the Biopol Chemicals IPO is to raise ₹31.26 crores. On the other hand, Biopol Chemicals has decided to utilise these funds in different ways.

• To the acquisition of industrial land
• To Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies 
• To General Corporate Expenses.

Should I Invest in the Biopol Chemicals IPO?

Explore the pros and cons of Biopol Chemicals to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits over the coming decades. 

Pros of the Biopol Chemicals IPO

• The company has quality certification and quality assurance.
• The company has an experienced promoter and management team.
• The company has Export operations in Bangladesh

Cons of the Biopol Chemicals IPO

• The company has an Expansion & execution risk.
• The company has a customer concentration risk.
• The company has a dependence on the sector & raw materials

How to Apply for the Biopol Chemicals IPO?

Check the steps mentioned below to apply for Biopol Chemicals Ltd.

• Step 1: Conduct thorough research on the Biopol Chemicals IPO GMP, subscription status, issue size, lot size, and other details. 
• Step 2: Open a demat account with Univest to access real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section. 
• Step 3: Make a bid for 2 lots of 2,400 shares worth ₹2,59,200
• Step 4: You will receive a mandate request after making a bid. Approve the request to proceed further.    

Note: You can apply for the Biopol Chemicals IPO across multiple demat accounts to increase your chances of allotment. 

How to Check the Biopol Chemicals IPO Allotment Status?

You can check for the Biopol Chemicals IPO allotment in different ways. These include BSE and the registrar portal. Follow the steps below to check your allotment status online.

Check On NSE

• Visit the NSE Official Site
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the Biopol Chemicals IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal.
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your Biopol Chemicals IPO allotment status.

Let’s Wrap

Biopol Chemicals IPO is a bookbuilding issue of shares worth ₹31.26 crores. The shares of Biopol Chemicals Limited will be listed on NSE and SME on its tentative listing date of 13th February 2026. Researching the Biopol Chemicals IPO GMP and reviews is highly recommended to achieve your desired profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.

Open a demat account on Univest now to initiate your investment journey!

FAQs on Biopol Chemicals IPO

How is the Biopol Chemicals IPO?

Ans. Currently, on 6th February 2026, the Biopol Chemicals GMP (Grey Market Premium) stands at ₹0. It indicates that the estimated listing price could be ₹108 per share. It is a bookbuilding IPO of ₹31.26 shares. The face value of each Biopol Chemicals share is ₹10 per share. 

What is the Biopol Chemicals IPO price?

Ans. The Biopol Chemicals IPO issue price band is set at ₹102 to ₹108 per share. 

Is the Biopol Chemicals IPO a good investment?

Ans. Biopol Chemicals Limited’s revenue increased by 181.98% from ₹17.43 crores in March 2024 to ₹49.15 crores in March 2025. Moreover, the company’s PAT increased by 46.28% from ₹2.96 crores in March 2024 to ₹4.33 crores in March 2025.

Who is the registrar of the Biopol Chemicals IPO?

Ans. Bigshare Services Private Limited is the registrar for the Biopol Chemicals IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Biopol Chemicals allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.

What is the issue size of the Biopol Chemicals IPO? 

Ans. Biopol Chemicals IPO is a bookbuilding IPO of ₹31.26 crores. Moreover, the IPO is set to open on 6th February 2026 and close on 10th February 2026. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Biopol Chemicals IPO, download the Biopol Chemicals IPO RHP and Biopol Chemicals IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Recent Article

CKK Retail Mart IPO GMP & Subscription Status: Day 2 IPO Live Updates

Hannah Joseph Hospital IPO Listing at 7.14% Discount at ₹65 Per Share

Grover IPO GMP & Review: Apply or Avoid? Key Details for Investors

Brandman Retail IPO GMP Analysis: Apply or Avoid Decision for Investors

Capri Global Capital Q3 Results 2026 Highlights: Net Profit Surged by 99.43% & Revenue Up 48.67% YoY